For the fourth consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $150 million fund for FY25. In advance of pre-application deadlines, we are sharing the FY25 funding mechanisms, award amounts, maximum direct costs and how to apply. Want to learn more about […]
May 4-10, 2025 There are lots of ways to get involved in Sign up for our awareness week webinar: Myths vs Facts on May 8 PN Myths vs. Facts: Deepening Understanding & Raising Awareness Want to break down misconceptions of PN and address some common gaps in knowledge on the topic? Shanna Patterson, MD, MS, […]
Read More… from Get involved in Peripheral Neuropathy Awareness Week
For the first time, we organized Neuropathy Advocacy Day and took our message directly to Congress. On March 18, 2025, staff and board members from the Foundation traveled to Washington, D.C. to speak up for the 30 million Americans who have peripheral neuropathy (PN). Our visit was urgent because earlier this month, Congress passed a […]
Peripheral neuropathy (PN) is vastly under-researched, despite its prevalence. While over 30 million Americans live with PN, the National Institutes of Health (NIH) funded less than $200 million in PN research from its $47 billion annual budget in 2024. That is less than $7 per PN patient. Neurological conditions are now the leading cause of […]
Read More… from Advocating for PN research: the critical need for research dollars
The Foundation for Peripheral Neuropathy (FPN) is pleased to announce the 2024 Clinical Research Training Scholarship (CRTS) recipient for peripheral neuropathy (PN), Francesco E. Michelassi, MD, PhD, Neuromuscular Research Fellow, Columbia University Irving Medical Center. Michelassi’s research is fully funded by FPN and will focus on chemotherapy-induced peripheral neuropathy (CIPN), by studying how a chemotherapy […]
Read More… from Clinical Research Training Scholarship Recipient Announced
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease where the body’s natural defenses, like antibodies, attack the covering of the nerves, called myelin, and damage nerve function. While symptoms aren’t the same for everyone, CIDP can make your arms and legs feel weak and slow your movements. The purpose of the ARISE Study is […]
The Foundation for Peripheral Neuropathy and the Department of Defense Peer-Reviewed Medical Research Program Co-Host March 8, 2023, Webinar About Award Pre-Applications CHICAGO, Feb. 28, 2023 /PRNewswire/ — For the third consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $370 million fund. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) […]
What It Is In response to the tireless advocacy and outreach from the peripheral neuropathy (PN) community, Congress designated peripheral neuropathy as a condition in the Peer Reviewed Medical Research Program (PRMRP) in the annual Defense Appropriations Act during fiscal years 2021 through 2023. During that time, the Department of Defense funded more than $13 million in […]
Read More… from Call to Action 2023 – Peer Reviewed Medical Research Program!
Best-selling author of “The End of Your Life Book Club” and FPN friend, Will Schwalbe, has written a new book, “We Should Not Be Friends.” Chronicling a forty-year improbable, life-changing friendship, this warm, funny, irresistible book also explores Schwalbe’s experience with small fiber neuropathy. “We Should Not Be Friends is as funny, warm, brutally honest […]
Read More… from Book Fundraiser to Benefit FPN: Order by Feb. 21
A study entitled “Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary” was published on December 29, 2021, in the journal Neurology®. The Foundation for Peripheral Neuropathy (FPN) is pleased to announce that Lindsay Colbert, Executive Director, was among the few esteemed authors on the subcommittee for this important review and update. […]
Read More… from AAN’s New Painful Diabetic Polyneuropathy Guidelines